Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance.

Weike Li,Ravi Chakra Turaga,Xin Li,Malvika Sharma, Zahra Enadi, Sydney Nicole Dunham Tompkins, Kyle Christian Hardy,Falguni Mishra,Jun Tsao,Zhi-Ren Liu,Daping Fan,Ming Luo

Molecular Therapy - Oncolytics(2019)

引用 10|浏览3
暂无评分
摘要
Despite reports of successful clinical cases, many tumors appear to resist infection by oncolytic viruses (OVs). To circumvent this problem, an armed vesicular stomatitis virus was constructed by inserting a transgene to express Smac/DIABLO during virus infection (VSV-S). Endogenous Smac in HeLa cells was diminished during wtVSV infection, whereas the Smac level was enhanced during VSV-S infection. Apoptosis was readily induced by VSV-S, but not wtVSV, infection. More importantly, the tumor volume was reduced to a larger extent when xenografts of 4T1 cells in BALB/c mice and OV-resistant T-47D cells in nude mice were intratumorally injected with VSV-S. VSV-S represents a novel mechanism to overcome tumor resistance, resulting in more significant tumor regression due to enhanced apoptosis.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要